Clinical Trials Browser

Phase 2 × Ovarian Neoplasms × Auranofin × Clear all

NCT03456700 2025-05-08

Auranofin and Sirolimus in Treating Participants With Ovarian Cancer

Phase 2 Terminated

22 enrolled 9 charts

Ovarian Neoplasms